Bailie Moorhead, Niva Shrestha, Alvin Boyd Newman-Caro, Sydney L. Vangeli, Victoria N. Lussier, Mark I. Grijalva, Margaret E. Giro, Danielle Natividad Jackson, Tianna M. Mack, Zackary L. Herrle, Marcheta Hill, Gretchen Rodriguez, Rachael Singer, Cynthia Williams, A. Nwanguma, Enyinnaya Merengwa, Rachel Pittman, Rebecca L. Sanchez
{"title":"确定得克萨斯州公共卫生 8 区各医院提交抗菌药物分离物的障碍","authors":"Bailie Moorhead, Niva Shrestha, Alvin Boyd Newman-Caro, Sydney L. Vangeli, Victoria N. Lussier, Mark I. Grijalva, Margaret E. Giro, Danielle Natividad Jackson, Tianna M. Mack, Zackary L. Herrle, Marcheta Hill, Gretchen Rodriguez, Rachael Singer, Cynthia Williams, A. Nwanguma, Enyinnaya Merengwa, Rachel Pittman, Rebecca L. Sanchez","doi":"10.1177/17571774241235101","DOIUrl":null,"url":null,"abstract":"The Antimicrobial Resistance Laboratory Network (AR Lab Network) was developed by the CDC to detect emerging antimicrobial-resistant (AR) threats and prevent outbreaks. However, low submission rates of AR isolates limit the potential of the AR Lab Network to address antimicrobial resistance (AMR). The aim of this study was to investigate barriers to submission of AR isolates in acute care hospitals (ACHs) and critical access hospitals (CAHs) within Texas Public Health Region 8 (PHR8) counties. A survey was designed and emailed to laboratory professionals to identify barriers to AR isolate submission. Responses were analyzed using 2-sided Fisher’s exact tests to identify associations between responses and respondent characteristics. Of the 33 hospitals within PHR8 invited to participate in the survey, responses were received from 21, a response rate of 63.6%. Lack of awareness of the AR Lab Network was the most frequently cited barrier to submission (65.4% of respondents). Other reported barriers to submission included lack of laboratory staff time (57.7%), lack of training with the submission process (34.6%), lack of personnel certified to ship infectious substances (23.1%), and lack of laboratory/shipping supplies (23.1%). Regardless of the respondent’s role, time in that role, or type of hospital in which they worked, the most common barrier to isolate submission was lack of awareness of the AR Lab Network. In the future, we will address the identified barriers by implementing educational outreach programs about AMR and the AR Lab Network for hospitals and other healthcare facilities within PHR8.","PeriodicalId":16094,"journal":{"name":"Journal of Infection Prevention","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2024-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Determining barriers to submitting antimicrobial-resistant isolates among hospitals in Texas Public Health Region 8\",\"authors\":\"Bailie Moorhead, Niva Shrestha, Alvin Boyd Newman-Caro, Sydney L. Vangeli, Victoria N. Lussier, Mark I. Grijalva, Margaret E. Giro, Danielle Natividad Jackson, Tianna M. Mack, Zackary L. Herrle, Marcheta Hill, Gretchen Rodriguez, Rachael Singer, Cynthia Williams, A. Nwanguma, Enyinnaya Merengwa, Rachel Pittman, Rebecca L. Sanchez\",\"doi\":\"10.1177/17571774241235101\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The Antimicrobial Resistance Laboratory Network (AR Lab Network) was developed by the CDC to detect emerging antimicrobial-resistant (AR) threats and prevent outbreaks. However, low submission rates of AR isolates limit the potential of the AR Lab Network to address antimicrobial resistance (AMR). The aim of this study was to investigate barriers to submission of AR isolates in acute care hospitals (ACHs) and critical access hospitals (CAHs) within Texas Public Health Region 8 (PHR8) counties. A survey was designed and emailed to laboratory professionals to identify barriers to AR isolate submission. Responses were analyzed using 2-sided Fisher’s exact tests to identify associations between responses and respondent characteristics. Of the 33 hospitals within PHR8 invited to participate in the survey, responses were received from 21, a response rate of 63.6%. Lack of awareness of the AR Lab Network was the most frequently cited barrier to submission (65.4% of respondents). Other reported barriers to submission included lack of laboratory staff time (57.7%), lack of training with the submission process (34.6%), lack of personnel certified to ship infectious substances (23.1%), and lack of laboratory/shipping supplies (23.1%). Regardless of the respondent’s role, time in that role, or type of hospital in which they worked, the most common barrier to isolate submission was lack of awareness of the AR Lab Network. In the future, we will address the identified barriers by implementing educational outreach programs about AMR and the AR Lab Network for hospitals and other healthcare facilities within PHR8.\",\"PeriodicalId\":16094,\"journal\":{\"name\":\"Journal of Infection Prevention\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2024-02-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection Prevention\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/17571774241235101\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/17571774241235101","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
摘要
抗菌药耐药性实验室网络(AR Lab Network,AR 实验室网络)由美国疾病预防控制中心(CDC)开发,旨在检测新出现的抗菌药耐药性(AR)威胁并预防疫情爆发。然而,AR 分离物的低提交率限制了 AR 实验室网络解决抗菌药耐药性 (AMR) 问题的潜力。本研究旨在调查德克萨斯州公共卫生第 8 区 (PHR8) 县内的急症护理医院 (ACH) 和重症监护医院 (CAH) 在提交 AR 分离物方面遇到的障碍。我们设计了一份调查问卷,并通过电子邮件发送给实验室专业人员,以确定提交 AR 分离物的障碍。我们使用双侧费雪精确检验对回复进行了分析,以确定回复与受访者特征之间的关联。在受邀参与调查的 33 家 PHR8 医院中,收到了 21 家医院的回复,回复率为 63.6%。对 AR 实验室网络缺乏了解是最常提到的提交障碍(65.4% 的受访者)。其他报告的递交障碍包括实验室工作人员时间不足(57.7%)、缺乏递交流程培训(34.6%)、缺乏有资格运输传染性物质的人员(23.1%)以及缺乏实验室/运输用品(23.1%)。无论受访者的角色、任职时间或所在医院的类型如何,提交分离物的最常见障碍都是缺乏对 AR 实验室网络的了解。今后,我们将通过在 PHR8 内为医院和其他医疗机构实施有关 AMR 和 AR 实验室网络的教育推广计划来解决已发现的障碍。
Determining barriers to submitting antimicrobial-resistant isolates among hospitals in Texas Public Health Region 8
The Antimicrobial Resistance Laboratory Network (AR Lab Network) was developed by the CDC to detect emerging antimicrobial-resistant (AR) threats and prevent outbreaks. However, low submission rates of AR isolates limit the potential of the AR Lab Network to address antimicrobial resistance (AMR). The aim of this study was to investigate barriers to submission of AR isolates in acute care hospitals (ACHs) and critical access hospitals (CAHs) within Texas Public Health Region 8 (PHR8) counties. A survey was designed and emailed to laboratory professionals to identify barriers to AR isolate submission. Responses were analyzed using 2-sided Fisher’s exact tests to identify associations between responses and respondent characteristics. Of the 33 hospitals within PHR8 invited to participate in the survey, responses were received from 21, a response rate of 63.6%. Lack of awareness of the AR Lab Network was the most frequently cited barrier to submission (65.4% of respondents). Other reported barriers to submission included lack of laboratory staff time (57.7%), lack of training with the submission process (34.6%), lack of personnel certified to ship infectious substances (23.1%), and lack of laboratory/shipping supplies (23.1%). Regardless of the respondent’s role, time in that role, or type of hospital in which they worked, the most common barrier to isolate submission was lack of awareness of the AR Lab Network. In the future, we will address the identified barriers by implementing educational outreach programs about AMR and the AR Lab Network for hospitals and other healthcare facilities within PHR8.
期刊介绍:
Journal of Infection Prevention is the professional publication of the Infection Prevention Society. The aim of the journal is to advance the evidence base in infection prevention and control, and to provide a publishing platform for all health professionals interested in this field of practice. Journal of Infection Prevention is a bi-monthly peer-reviewed publication containing a wide range of articles: ·Original primary research studies ·Qualitative and quantitative studies ·Reviews of the evidence on various topics ·Practice development project reports ·Guidelines for practice ·Case studies ·Overviews of infectious diseases and their causative organisms ·Audit and surveillance studies/projects